ISRG vs NVS
ISRG: Intuitive Surgical is the dominant innovator and market leader in robotic-assisted surgical platforms, driving a shift toward minimally invasive clinical outcomes. NVS: Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
Side-by-side fundamentals
| Metric | ISRG | NVS | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $356.83 | $156.11 | |
| Market cap as of 2026-08-03 | $126.1B | $232.1B | |
| P/E as of 2026-08-03 | 39.77 | 22.53 | NVS lower |
| PEG as of 2026-08-03 | 2.42 | 3.66 | ISRG lower |
| Net margin as of 2026-08-03 | +28.4% | +22.5% | ISRG higher |
| Gross margin as of 2026-08-03 | +66.7% | +75.0% | NVS higher |
| Operating margin as of 2026-08-03 | +31.3% | +29.9% | ISRG higher |
| ROE as of 2026-08-03 | +17.8% | +29.9% | NVS higher |
| ROA as of 2026-08-03 | +15.5% | +11.1% | ISRG higher |
| Debt / equity as of 2026-08-03 | 0.00 | 1.18 | ISRG lower |
| Revenue growth (YoY) as of 2026-08-03 | +20.7% | +3.3% | ISRG higher |
| Revenue CAGR (3y) SEC XBRL | +17.4% | n/a | |
| Dividend yield as of 2026-08-03 | n/a | +2.9% | |
| Beta as of 2026-08-03 | 1.46 | 1.17 | |
| 1-year return as of 2026-07-27 close | -28.0% | +32.6% | NVS higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.